|
Volumn 1, Issue 6, 2004, Pages 444-455
|
Emerging strategies and applications of pharmacogenomics.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL TRIAL;
DECISION MAKING;
DRUG DESIGN;
DRUG INDUSTRY;
GENOTYPE;
HUMAN;
ONCOLOGY;
PHARMACOGENETICS;
PHENOTYPE;
REVIEW;
SINGLE NUCLEOTIDE POLYMORPHISM;
CLINICAL TRIALS;
DECISION MAKING;
DRUG DESIGN;
DRUG INDUSTRY;
GENOTYPE;
HUMANS;
MEDICAL ONCOLOGY;
PHARMACOGENETICS;
PHENOTYPE;
POLYMORPHISM, SINGLE NUCLEOTIDE;
MLCS;
MLOWN;
|
EID: 15244348704
PISSN: 14739542
EISSN: None
Source Type: Journal
DOI: 10.1186/1479-7364-1-6-444 Document Type: Review |
Times cited : (10)
|
References (82)
|